BD To Present At CSFB Annual Healthcare Conference.

Business Editors/Health & Medical Writers

FRANKLIN LAKES, N.J.--(BUSINESS WIRE)--Nov. 13, 2000

BD (Becton, Dickinson and Company) (NYSE:BDX) announced today it will participate in the Credit Suisse First Boston (CSFB) Annual Healthcare Conference. A presentation will be made by Edward J. Ludwig, president and chief executive officer, on November 16, 2000 (8 a.m. Mountain Time; 10 a.m. Eastern Time) at the Arizona Biltmore, 24th Street & Missouri Avenue, Phoenix, Arizona.

Mr. Ludwig's presentation will include a discussion of results for the fourth quarter and fiscal year 2000, as well as information regarding BD's business segments, BD Biosciences, BD Clinical Laboratory Solutions and BD Medical Systems.

This conference, including Mr. Ludwig's presentation, will be simultaneously Webcast. The Web link will be made available later this week, and will be publicized on the Company's Website, www.bd.com.

BD is a medical technology company that manufactures and sells a broad range of supplies, devices and systems for use by healthcare professionals, medical research institutions, industry and the general public. For the fiscal year ended September 30, 2000, BD reported total revenues of $3.6 billion.

This press release may contain certain forward-looking statements (as defined under Federal securities laws) regarding the Company's performance, including future revenues, products and income, or events or developments that the Company expects to occur or anticipates occurring in the future. All such statements are based upon current expectations of the Company and involve a number of business risks and uncertainties. Actual results could vary materially from anticipated results described, implied or projected in any forward-looking statement. Factors that could cause actual results to vary materially from any forward-looking statement include, but are not limited to: competitive factors; pricing and market share pressures; uncertainties of litigation; the Company's ability to achieve sales and earnings forecasts, which are based on sales volume and product mix assumptions, to achieve its cost savings objectives, and to achieve anticipated synergies and other cost savings in connection with acquisitions; changes in regional, national or foreign economic conditions; increases in energy costs; fluctuations in costs and availability of raw materials and in the Company's ability to maintain favorable supplier arrangements and relationships; changes in interest or foreign currency exchange rates; delays in product introductions; and changes in health care or other governmental regulation, as well as other factors discussed in this press release and in the Company's filings with the Securities and Exchange Commission. We do not intend to update any forward-looking statements.